Peculiarities of the Interaction of the Bacteriolytic Protease Blp from Lysobacter capsici XL1 with the Cell Wall of Staphylococcus aureus 209P
International Journal of Molecular Sciences · 10.06.2026 · 27 (12) · 5246
DOI: 10.3390/ijms27125246 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.06.2026. Verfasst von Irina Kudryakova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbial Cell Surface Biochemistry, G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, FRC PSCBR, Russian Acade…. Hauptthemen laut MEDLINE: Lysobacter, Staphylococcus aureus, Cell Wall, Bacterial Proteins. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The Lysobacter capsici XL1 β-lytic protease (Blp) is a bacteriolytic enzyme that hydrolyzes peptide bonds in the interpeptide bridge of the peptidoglycan of Gram-positive bacteria, including antibiotic-resistant strains of pathogenic bacteria. The Blp has been extensively characterized. The only unexplored aspect is the mechanism by which this enzyme recognizes target cells. In this work, we demonstrated for the first time that the Blp structure contained a C-terminal subdomain that can be responsible for this interaction. Molecular modeling suggested a hydrophobic nature of the interaction between the Blp and peptidoglycan. Model mutant forms of the Blp, which have fewer hydrophobic areas in the C-terminal subdomain, also had fewer sites for potential interaction with the ligand. Wet lab experiments showed that these mutant Blp forms exhibited poorer binding to peptidoglycan and living Staphylococcus aureus 209P cells, resulting in decreased bacteriolytic and proteolytic activity. Amino acid residues N136 and Y160 in the C-terminal subdomain were identified and can be important for the interaction of the enzyme with target cells. Further research into the mechanism of target cell recognition by bacterial bacteriolytic proteases will enable the use of this knowledge to expand the specificity of action of these enzymes, including as antimicrobial agents for medical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbial Cell Surface Biochemistry, G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, FRC PSCBR, Russian Academy of Sciences, 5 Prosp. Nauki, 142290 Pushchino, Russia.
- Center for Bio- and Medical Technologies, 121205 Moscow, Russia.
- Institute of Protein Research, Russian Academy of Sciences, 4 Institutskaya Str., 142290 Pushchino, Russia.
ORCID-Profile: Irina Kudryakova, Egor Bulavko, Dmitry Ivankov, Bogdan Melnik
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Kudryakova, I., Afoshin, A., Bulavko, E., Ivankov, D., Melnik, B., Leontyevskaya, E., & Leontyevskaya, N. (2026). Peculiarities of the Interaction of the Bacteriolytic Protease Blp from Lysobacter capsici XL1 with the Cell Wall of Staphylococcus aureus 209P. International Journal of Molecular Sciences, 27(12), 5246. https://doi.org/10.3390/ijms27125246
Vancouver
Kudryakova I, Afoshin A, Bulavko E, Ivankov D, Melnik B, Leontyevskaya E, et al. Peculiarities of the Interaction of the Bacteriolytic Protease Blp from Lysobacter capsici XL1 with the Cell Wall of Staphylococcus aureus 209P. International Journal of Molecular Sciences. 2026;27(12):5246. doi:10.3390/ijms27125246
BibTeX
@article{Kudryakova2026,
author = {Kudryakova, Irina and Afoshin, Alexey and Bulavko, Egor and Ivankov, Dmitry and Melnik, Bogdan and Leontyevskaya, Elena and Leontyevskaya, Natalia},
title = {Peculiarities of the Interaction of the Bacteriolytic Protease Blp from Lysobacter capsici XL1 with the Cell Wall of Staphylococcus aureus 209P},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5246},
doi = {10.3390/ijms27125246}
}
EUVIMED